|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Influence of lungcollapse distribution on the physiologic response to recruitmentmaneuvers during noninvasive continuous positive airwaypressure显示文摘 | Cammarota G Vaschetto R Dellapiazza F | 2011 | Turucz Elntensive Care Med2011，37，7： | 1 |
| 2 | The syn- thetic oleanane triterpenoid, CDDO- methyl ester, is a potent antiangiogenic agent 显示文摘 | VANNINI N LORUSSO G CAMMAROTA R | 2007 | Mol Cancer Ther2007，6，121： | 1 |
| 3 | Effects of propofol on patient-ventilator synchrony and interaction during pressure support ventilation and neurally adjusted ventilatory assist显示文摘 | Vaschetto R Cammarota G Colombo D | 2014 | Crit Care Med2014，42，： | 1 |
| 4 | Efficacy of two one-week rabeprazole/levofoxacin-based triple therapies for Helicobacter pylori infection显示文摘 | Cammarota G Clanci R Cannizzaro O | 2000 | Aliment Pharmacol Ther2000，14，： | 1 |
| 5 | High-dose versus low-dose clarithromycin in 1-week tripie therapy including rabeprazole and levofloxacin,for Helicobacter pylori eradication显示文摘 | Cammarota G Cianci R Cannizzaro O | | 0，，： | 1 |
| 6 | Angiogenesis:prognostic significance in laryngeal cancer显示文摘 | Cammarota R Giordano C | 1998 | Anticancer Res1998，18，6： | 1 |
| 7 | High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levefloxacin, for Helicobacter pylorieradication 显示文摘 | CAMMAROTA G CIANCI R CANNIZZARO O | 2004 | J Clin Gastroenterol2004，38，2： | 1 |
| 8 | High-dose versus lowdose elarithromyein in 1-week triple therapy, including rabeprazole and levofloxaein, for Helicobacter pylori eradication 显示文摘 | Cammarota G Cianei R Cannizzaro O | 2004 | J Clin Gastroenterol2004，38，2： | 1 |
| 9 | Efficacy of two one-week rabepraz01e/levofloxacin-based triple therapies for Helicobacter pylori infection 显示文摘 | Cammarota G Cianci R Cannizzaro O | 2000 | Aliment Pharmacol Ther2000，14，： | 1 |
| 10 | High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication显示文摘 | Cammarota G Cianci R Cannizzaro O | 2004 | Clin Gastroenterol2004，38，2： | 1 |
| 11 | High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication显示文摘 | Cammarota G Cianci R Cannizzaro O | 2004 | J Clin Gastroenterol2004，38，2： | 1 |
| 12 | High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabep razole and levofloxacin, for Helicobacter pylori eradication 显示文摘 | Cammarota G Cianci R Cannizzaro O | 2004 | J Clin Gastroenterol2004，38，2： | 1 |
| 13 | Attrition phenomena during fluidized bed combustion of granulated and mechanically dewatered sewage sludges显示文摘 | Cammarota A Chirone R Salatino P | 2005 | Proceedings of the Combustion Institute2005，30，2： | 1 |
| 14 | The involve- ment of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 显示文摘 | CAMMAROTA G IANIRO G CIANCI R | 2015 | Pharmacology & Therapeutics2015，149，： | 1 |
| 15 | Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth 显示文摘 | Cantelmo AR Cammarota R Noonan DM | 2010 | Oncogene2010，29，38： | 1 |
| 16 | High-dose versus low-dose clarithromycin in 1-week triple therapy,including rabeprazole and levofloxacin,for Helicobacter pylori eradication显示文摘 | Cammarota G Cianci R Cannizzaro O | 2004 | J Clin Gastroenterology2004，38，2： | 1 |
| 17 | High-dose versus low-dose clarithromycin in l-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication显示文摘 | Cammarota G Cianci R Cannizzaro O | 2004 | J Clin Gastroenterol2004，38，2： | 1 |
| 18 | High-dose versus low-dose clarithromycin in 1-week triple therapy,including rabeprazole and levofloxaxin,for Helicobacter pylori eradication显示文摘 | Cianci R Cannizzaro O | 2004 | J Clin Gastroenterol2004，38，： | 1 |
| 19 | Efficacy of two one week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection显示文摘 | Cammarota G Cianci R Cannizzaro O | 2000 | Aliment Pharmacol Ther2000，14，10： | 1 |
| 20 | High-doseversus low-doseclarithromycin in 1-week triple therapy,in-cluding rabeprazole and levofloxacin,for Helicobacter pylorieradication显示文摘 | Cammarota G Cianci R Cannizzaro O | 2004 | J Clin Gastroenterol2004，38，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员